Lorlatinib acetate

CAS: 1924207-18-0

Ref. 3D-ZBD20718

Produktinformation

• Name: Lorlatinib acetate
• Marke: Biosynth
• Beschreibung: Lorlatinib acetate is a small-molecule tyrosine kinase inhibitor, which is a synthetic pharmaceutical compound designed to specifically inhibit the activity of anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (ROS1). This compound is derived through complex chemical synthesis to ensure specificity and potency in its mechanism of action. Lorlatinib acetate functions by selectively binding to the ATP-binding site of ALK and ROS1, leading to the inhibition of downstream signaling pathways that promote tumor cell proliferation and survival. This targeted action results in the interruption of cancer cell growth and the induction of apoptosis in cancer cells harboring ALK and ROS1 aberrations.

Chemische Eigenschaften

• Molekulargewicht: 466.5 g/mol
• Formel: C₂₃H₂₃FN₆O₄
• Reinheit: Min. 95%